Ventricular Arrhythmias
📧 Sign up to get email alerts when something new happens for Ventricular Arrhythmias.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: EDEN Intracardiac Electrogram Recording and Classifying System [NA]
The EDEN intracardiac electrogram recording and classifying system is being studied for use in ventricular arrhythmias, with the trial curre…
-
FDA approval · 2026-03-23FDA Approved: MEXILETINE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved an original ANDA for Mexiletine hydrochloride, a generic antiarrhythmic drug manufactured by Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Treatment of Focal Ventricular Tachycardias Using a Pulsed Field Ablation From a Point Ablation Catheter Short Title FOCUS-PFA [NA]
This document reports an ongoing clinical trial (FOCUS-PFA) evaluating pulsed field ablation using a point ablation catheter to treat focal …
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Cardiac Sympathetic Denervation in Patients With Refractory Arrhythmic Storm: a Single-center Case Series
This document summarizes a completed single-center case series evaluating cardiac sympathetic denervation for refractory arrhythmic storm. T…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Do QT-Prolonging Drugs Cause Major Adverse Cardiac Events in Hospitalized Adults?
A recruiting clinical trial assessing whether drugs that prolong the QT interval lead to major adverse cardiac events in hospitalized adults…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm [Phase 3]
Phase 3 clinical trial evaluating prophylactic amiodarone in critically ill patients admitted after out-of-hospital cardiac arrest with an i…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: PRIMARY Ancillary Substudy [NA]
This is a PRIMARY trial ancillary substudy that is currently recruiting and focuses on patients with mitral valve prolapse, left ventricular…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Symptoms and Coping Strategies Among Patients With Implantable Cardioverter Defibrillator
Completed clinical trial examining symptoms and coping strategies among patients with implantable cardioverter defibrillators.
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse [Phase 3]
Phase 3 trial evaluating whether adding flecainide to metoprolol more effectively suppresses ventricular arrhythmias in arrhythmic mitral va…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Effects of Upgrading From Right Ventricular Pacing to Cardiac Resynchronization Therapy and Comparison With Dual-Chamber Defibrillator
The study evaluated upgrading from right ventricular pacing to cardiac resynchronization therapy and compared outcomes to a dual-chamber def…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Transcutaneous Vagus Nerve Stimulation for Ventricular Arrhythmias [NA]
The document is a clinical trial registration for transcutaneous vagus nerve stimulation to treat ventricular arrhythmias, including prematu…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Ultra High Resolution CT to Assess Role of Intramyocardial Fat and Delayed Enhancement in Ventricular Arrhythmogenesis
This update describes a Johns Hopkins–led clinical trial using ultra-high resolution CT to investigate intramyocardial fat and delayed enhan…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Targeted Potassium Levels for Prevention of ICD Therapy [Phase 4]
Phase 4 clinical trial update examining targeted potassium levels to prevent ICD therapies in patients with ventricular arrhythmias, cardiac…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Impact of Catheter Ablation of Frequent Premature Ventricular Complexes in Treating Subtle Left Cardiomyopathy [NA]
A clinical trial from Ain Shams University studied catheter ablation of frequent premature ventricular complexes in patients with subtle lef…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: WHEN DO WE HAVE to PERFORM CARDIAC MAGNETIC RESONANCE in PATIENTS REFERRED for PREMATURE VENTRICULAR COMPLEXES by THEIR CARDIOLOGISTS
This clinical trial update examines when cardiac magnetic resonance imaging should be performed for patients with premature ventricular comp…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Evaluation of Electrocardiographic Measurements by High Density Electrode ECG [NA]
A clinical trial led by University Hospital, Bordeaux is evaluating high-density electrode ECG measurements for ventricular arrhythmias and …
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Changes in Electrocardiographic (ECG) Ventricular Repolarization and Transthoracic Impedance Cardiography (ICG) Parameters in Patients with COVID-19 and After the Disease: Persistence and Prognostic Significance of These Changes
The document reports a clinical trial examining changes in ECG ventricular repolarization and impedance cardiography in patients with COVID-…
-
CLINICAL_TRIALS research · 2024-09-24Clinical Trial Update: Hybrid Score to Predict OTVA-SOO in Patients with Wide Basal QRS
The clinical trial is currently recruiting to evaluate a Hybrid Score for predicting OTVA-SOO in patients with wide basal QRS.
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Characterization of Left Atrial Substrate in Patients With Ventricular Arrhythmias
A recruiting clinical study at Universitair Ziekenhuis Brussel investigating the left atrial substrate in patients with ventricular arrhythm…
-
FDA approval · 2024-05-15FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's supplemental application for sotalol hydrochloride (generic). This action authorizes changes to the previously approved …
-
FDA approval · 2024-01-12FDA Approved: SOTYLIZE — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for SOTYLIZE (sotalol hydrochloride) from Azurity Pharmaceuticals, Inc.
-
FDA approval · 2023-08-29FDA Approved: MEXILETINE HYDROCHLORIDE — Supplemental Application (Senores Pharmaceuticals, Inc.)
The FDA approved a supplemental application for a generic Mexiletine hydrochloride product from Senores Pharmaceuticals, Inc.
-
FDA approval · 2022-11-09FDA Approved: MEXILETINE HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved the original application for Mexiletine hydrochloride (generic) from Camber Pharmaceuticals.
-
FDA approval · 2022-09-08FDA Approved: FLECAINIDE ACETATE — Original Application (Epic Pharma, LLC)
FDA approved the original application for flecainide acetate tablets from Epic Pharma, LLC under ANDA215599.
-
FDA approval · 2022-05-25FDA Approved: MEXILETINE HYDROCHLORIDE — Original Application (Senores Pharmaceuticals, Inc.)
FDA approved the original application for Mexiletine hydrochloride (generic) from Senores Pharmaceuticals, Inc., adding a generic option. Th…